ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 651

$619K Total Retail Price of All Prescriptions

Rank: 29 out of 651

379 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maryland
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 298 271 64 1 2
FUROSEMIDE 276 271* 53 2 7
LEVOTHYROXINE SODIUM 264 240 55 3 3
SIMVASTATIN 246 229 54 4 4
HYDROCODONE-ACETAMINOPHEN 233 220 44 S3 5 21
METOPROLOL TARTRATE 212 207* 42 6 10
LISINOPRIL 203 198* 45 7 1
RAMIPRIL 201 188 37 8 80
PRAVASTATIN SODIUM 187 175 47 9 11
METFORMIN HCL 181 176* 47 10 6
HYDROCHLOROTHIAZIDE 175 159 46 11 9
TRAMADOL HCL 156 151* 33 12 14
WARFARIN SODIUM 155 150* 25 13 16
ATORVASTATIN CALCIUM 154 132 36 14 5
LORAZEPAM 154 149* 41 B 14 27
POTASSIUM CHLORIDE 147 135 32 16 25
SERTRALINE HCL 138 133* 25 17 20
METOPROLOL SUCCINATE 132 127* 27 18 12
JANTOVEN 127 <11 <11 19 64
ZETIA 127 122* 19 19 113
OMEPRAZOLE 124 102 32 21 8
POLYETHYLENE GLYCOL 3350 116 111* 18 22 58
RANITIDINE HCL 116 111* 18 22 24
DONEPEZIL HCL 112 112 11 24 34
CITALOPRAM HBR 111 106* 16 25 28
CLOPIDOGREL 110 105* 20 26 19
ALPRAZOLAM 105 89 19 B 27 23
ISOSORBIDE MONONITRATE ER 96 96 11 28 70
DIOVAN 91 91 13 29 59
ATENOLOL 87 75 16 30 13
OXYCODONE HCL 85 60 12 S2 31 33
CARBIDOPA-LEVODOPA 84 <11 <11 32 107
NAMENDA 83 <11 <11 33 47
TERAZOSIN HCL 80 80 15 34 112
PANTOPRAZOLE SODIUM 80 75* 24 34 18
ZOLPIDEM TARTRATE 79 66 17 36 26
GABAPENTIN 71 66* 16 37 17
GEMFIBROZIL 68 63* 12 38 122
LOSARTAN POTASSIUM 64 64 12 39 15
PREDNISONE 62 57* 17 40 40
KETOCONAZOLE 61 56* 21 41 228
SPIRIVA 59 59 13 42 62
TAMSULOSIN HCL 59 54* 15 42 30
ALLOPURINOL 58 58 12 44 45
ADVAIR DISKUS 57 52* 15 45 44
HYDROXYZINE HCL 56 <11 <11 R 46 230
VENLAFAXINE HCL ER 50 <11 <11 47 104
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.